Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PATH
PATH logo

PATH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy UiPath Inc (PATH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
11.100
1 Day change
2.12%
52 Week Range
19.840
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

UiPath Inc is not a strong buy for a beginner investor with a long-term strategy at this time. While the company has shown positive financial growth in the latest quarter, the technical indicators suggest a bearish trend, and analysts have lowered price targets, reflecting cautious sentiment. Additionally, there are no strong proprietary trading signals or significant positive catalysts to justify immediate investment.

Technical Analysis

The MACD is negative and expanding, RSI is neutral at 34.896, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 11.725, with key support at 10.942 and resistance at 12.508. Overall, the technical indicators suggest a bearish trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
4

Positive Catalysts

  • The company's Q4 financials showed strong revenue growth (+13.56% YoY), significant net income growth (+101.69% YoY), and EPS improvement (+111.11% YoY). Additionally, the appointment of a new Chief Product and Technology Officer signals a focus on technological innovation, which could support long-term growth.

Neutral/Negative Catalysts

  • Analysts have broadly lowered price targets, citing concerns about flat organic net new ARR growth and limited operating margin expansion. Technical indicators are bearish, and there is no recent congress trading data or strong hedge fund/insider trading trends to support a positive outlook.

Financial Performance

In Q4 2026, UiPath reported revenue of $481.1M (+13.56% YoY), net income of $104.46M (+101.69% YoY), and EPS of $0.19 (+111.11% YoY). However, gross margin declined slightly to 84.63% (-0.83% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets across the board, with most ratings being Neutral or Hold. The average price target is now in the $13-$15 range, reflecting cautious sentiment. While some analysts acknowledge positive AI adoption trends, they emphasize the need for sustained revenue growth to justify a more optimistic outlook.

Wall Street analysts forecast PATH stock price to rise
18 Analyst Rating
Wall Street analysts forecast PATH stock price to rise
2 Buy
15 Hold
1 Sell
Hold
Current: 10.870
sliders
Low
14
Averages
16.54
High
19
Current: 10.870
sliders
Low
14
Averages
16.54
High
19
BMO Capital
Market Perform
downgrade
$17 -> $14
AI Analysis
2026-03-16
Reason
BMO Capital
Price Target
$17 -> $14
AI Analysis
2026-03-16
downgrade
Market Perform
Reason
BMO Capital lowered the firm's price target on UiPath to $14 from $17 and keeps a Market Perform rating on the shares. The company's Q4 results reflected continued stabilization in net new annualized recurring revenue, which points to improving execution and a more durable growth profile, the analyst tells investors in a research note, adding however that investors will need more evidence of sustained AI monetization moving forward to further support the shares.
Evercore ISI
In Line
downgrade
$17 -> $13
2026-03-12
Reason
Evercore ISI
Price Target
$17 -> $13
2026-03-12
downgrade
In Line
Reason
Evercore ISI lowered the firm's price target on UiPath to $13 from $17 and keeps an In Line rating on the shares. While the outlook for FY27 suggests seasonally weighted growth, the potential for upside remains if AI initiatives continue to gain traction, says the analyst after a "solid" Q4 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PATH
Unlock Now

People Also Watch